Questcor Pharmaceuticals (QCOR -7.3%) takes a hit today on reports that Cerium Pharmaceuticals...
Questcor Pharmaceuticals (QCOR -7.3%) takes a hit today on reports that Cerium Pharmaceuticals has been granted an FDA orphan drug designation for Synacthen Depot, a synthetic equivalent of Acthar.
From other sites
at Zacks.com (Mar 24, 2015)
at Zacks.com (Mar 6, 2015)
at Nasdaq.com (Mar 3, 2015)
at Zacks.com (Feb 27, 2015)
at Nasdaq.com (Feb 12, 2015)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs